Sapid Agency in Juxta-Epithelial Perioral Fibrosclerotic Remodeling, Arecoline-Containing Chewable Formulation, Tar-Exposed Persons and Eubiotic Persons
Agape Photini
Broschiertes Buch

Sapid Agency in Juxta-Epithelial Perioral Fibrosclerotic Remodeling, Arecoline-Containing Chewable Formulation, Tar-Exposed Persons and Eubiotic Persons

Versandkostenfrei!
Versandfertig in 1-2 Wochen
25,99 €
inkl. MwSt.
PAYBACK Punkte
13 °P sammeln!
Oral submucous fibrosis (OSMF) is a chronic debilitating disease, that is progressive in nature and has significant malignant potential. The disease mainly involves the lamina propria and may later go on to involve the deeper tissues of the submucosa in its advanced stages, eventually leading to loss of its fibro-elasticity. This entity was first described in 600 B.C. by Sushruta by the name "Vidari". The disease was noted by Schwartz in the year 1952 in five Indian females residing in Kenya. He was the one who coined the term Atrophia idiopathica (trophica) mucosae oris. However, the true und...